If you or your child has asthma and/or taking asthma medication daily call 347-344-3000 for more information about joining an asthma registry and opportunities to participate in other asthma research studies.
This Phase III trial investigates if the incorporation of immunotherapy will improve progression-free survival (PFS) and maintain overall survival (OS) while simultaneously minimizing long-term morbidity and treatment-related mortality by reducing exposure to radiotherapy and high cumulative chemotherapy doses. The study will enroll patients ages 5 to 60…